These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Fixed-dose unfractionated heparin vs low-molecular-weight heparin for venous thromboembolism. Bhala N; Shah A; King A; Molugu C JAMA; 2007 Jan; 297(3):261; author reply 263. PubMed ID: 17227971 [No Abstract] [Full Text] [Related]
29. Management of deep vein thrombosis in cancer patients. Jahanzeb M J Natl Compr Canc Netw; 2005 Nov; 3 Suppl 1():S50-3. PubMed ID: 16280114 [No Abstract] [Full Text] [Related]
30. [Treatment of venous thrombosis in a cancer patient]. Lepäntalo A Duodecim; 2015; 131(7):637-44. PubMed ID: 26233981 [TBL] [Abstract][Full Text] [Related]
31. Cancer related venous thromboembolism - prophylaxis and therapy. Gary T Vasa; 2014 Jul; 43(4):245-51. PubMed ID: 25007902 [TBL] [Abstract][Full Text] [Related]
32. [Low molecular weight heparin--a safer anticoagulant in thrombosis and cancer]. Schulman S Lakartidningen; 2004 May; 101(19):1712-5. PubMed ID: 15188585 [No Abstract] [Full Text] [Related]
33. Effect of anticoagulant drugs in cancer. Falanga A; Piccioli A Curr Opin Pulm Med; 2005 Sep; 11(5):403-7. PubMed ID: 16093813 [TBL] [Abstract][Full Text] [Related]
34. Prophylaxis and treatment of venous thromboembolism in patients with cancer. Ageno W; Squizzato A Intern Emerg Med; 2006; 1(4):260-2. PubMed ID: 17217144 [No Abstract] [Full Text] [Related]
35. Efficacy of a low molecular weight heparin administered intravenously or subcutaneously in comparison with intravenous unfractionated heparin in the treatment of deep venous thrombosis. Certoparin-Study Group. Kirchmaier CM; Wolf H; Schäfer H; Ehlers B; Breddin HK Int Angiol; 1998 Sep; 17(3):135-45. PubMed ID: 9821025 [TBL] [Abstract][Full Text] [Related]